27 Oct 2022 , 08:12 AM
Net profit of Gland Pharma declined 20.14% to Rs 241.24 crore in the quarter ended September 2022 as against Rs 302.08 crore during the previous quarter ended September 2021. Sales declined 3.34% to Rs 1044.40 crore in the quarter ended September 2022 as against Rs 1080.47 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 1044.40 | 1080.47 | -3 |
| OPM % | 28.42 | 34.86 | – |
| PBDT | 360.75 | 426.78 | -15 |
| PBT | 324.08 | 400.67 | -19 |
| NP | 241.24 | 302.08 | -20 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
